Early onset of autoimmune disease by the retroviral integrase inhibitor raltegravir.

Proceedings of the National Academy of Sciences of the United States of America
Gabriele B Beck-EngeserMatthias Wabl

Abstract

Raltegravir is a recently, Food and Drug Administration-approved, small-molecule drug that inhibits retroviral integrase, thereby preventing HIV DNA from inserting itself into the human genome. We report here that the activity profile of raltegravir on the replication of murine leukemia virus is similar to that for HIV, and that the drug specifically affects autoimmune disease in mice, in which endogenous retroelements are suspected to play a role. While NZW and BALB/c mice, which do not succumb to autoimmune disease, are not affected by raltegravir, lupus-prone (NZBxNZW) F(1) mice die of glomerulonephritis more than a month earlier than untreated mice. Raltegravir-treated NZB mice, which share the H-2 haplotype with BALB/c mice, but which are predisposed to autoimmune hemolytic anemia, develop auto-antibodies to their red blood cells >3 months earlier than untreated mice of the same strain. Because nonautoimmune mice are not affected by raltegravir, we consider off-target effects unlikely and attribute the exacerbation of autoimmunity to the inhibition of retroviral integrase.

References

Sep 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·H M JäckM Wabl
Aug 1, 1974·American Journal of Clinical Pathology·J A Levy
Jul 1, 1967·The Journal of Experimental Medicine·R C Mellors, C Y Huang
Oct 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·S K ChattopadhyayD R Lowy
Aug 1, 1981·The Journal of Experimental Medicine·S IzuiF J Dixon
Aug 26, 1994·Science·B K FinckD Wofsy
Jan 1, 1994·Annual Review of Biochemistry·R A Katz, A M Skalka
Apr 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·F D BushmanR Craigie
Feb 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·J A Levy
Jul 3, 1999·The Journal of Biological Chemistry·D J Mazur, F W Perrino
Jun 7, 2000·Proceedings of the National Academy of Sciences of the United States of America·L MorelE K Wakeland
Jun 30, 2000·Virology·J B LorensJ M Bogenberger
Jul 3, 2002·Proceedings of the National Academy of Sciences of the United States of America·John G JuliasStephen H Hughes
Jun 1, 1959·British Journal of Cancer·F BIELSCHOWSKY, M BIELSCHOWSKY
Jul 16, 2004·Molecular and Cellular Biology·Masashi MoritaDeborah E Barnes
May 20, 2006·Science·Prapaporn PisitkunSilvia Bolland
Aug 23, 2006·Journal of Leukocyte Biology·Andrea Cara, Mary E Klotman
Sep 15, 2006·Springer Seminars in Immunopathology·Dwight H Kono, Argyrios N Theofilopoulos
Apr 19, 2007·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Min Ae Lee-KirschNorbert Hubner
Jul 10, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yang LiuChandra Mohan
Jun 4, 2008·European Journal of Immunology·Anna-Marie FairhurstEdward K Wakeland
Aug 8, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lucie BaudinoShozo Izui
Aug 30, 2008·Cell·Daniel B StetsonRuslan Medzhitov
Sep 23, 2008·The Journal of Biological Chemistry·Duane A LehtinenFred W Perrino
Jun 6, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kumiko YoshinobuShozo Izui

❮ Previous
Next ❯

Citations

Jul 21, 2010·Current Opinion in Rheumatology·Andras PerlPaul E Phillips
Jan 29, 2011·Journal of Virology·Yasuhiro KohAlan Engelman
Sep 3, 2010·Retrovirology·Robert A SmithA Dusty Miller
Nov 10, 2011·Retrovirology·Gabriele B Beck-EngeserMatthias Wabl
Apr 22, 2014·Autoimmunity Reviews·Laura IordacheUNKNOWN Associated authors
Aug 12, 2014·Seminars in Immunopathology·Tony N Marion, Arnold E Postlethwaite
Aug 30, 2011·Autoimmunity Reviews·David H Dreyfus
Jul 28, 2010·Autoimmunity Reviews·Lucie BaudinoShozo Izui
Dec 20, 2015·Immunological Reviews·Philipp Yu
Jan 20, 2012·The Journal of General Virology·Willie M GreggsLouis M Mansky
Sep 24, 2014·Seminars in Arthritis and Rheumatism·Lawrence O Okong'oChristian Scott
Jun 2, 2017·Cell Death & Disease·Mayilaadumveettil NishanaSathees C Raghavan
Sep 29, 2017·Expert Opinion on Investigational Drugs·Yingshan HanMark A Wainberg
Aug 1, 2015·Antiviral Chemistry & Chemotherapy·Michael T EadonZeruesenay Desta
Mar 16, 2017·World Journal of Biological Chemistry·Julia Grawenhoff, Alan N Engelman
Jul 27, 2010·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jean-François Mouscadet, Didier Desmaële
Mar 9, 2012·Expert Review of Anti-infective Therapy·Marie-Thérèse Labro
Jul 10, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Dan Eilat, Matthias Wabl
Jun 23, 2020·Cell Death Discovery·Namrata M NilavarSathees C Raghavan
Feb 11, 2021·Cell Death Discovery·Namrata M NilavarSathees C Raghavan
Mar 19, 2021·International Immunopharmacology·Namrata M Nilavar, Sathees C Raghavan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.